Log In
BCIQ
Print this Print this
 

HuMax-AXL-ADC

  Manage Alerts
Collapse Summary General Information
Company Genmab A/S
DescriptionAntibody-drug conjugate (ADC) targeting AXL receptor tyrosine kinase (AXL; UFO)
Molecular Target AXL receptor tyrosine kinase (AXL) (UFO)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$211.0M

$11.0M

$200.0M


 Deals Details
Get a free BioCentury trial today